Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Nault

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
The Canadian Journal of Cardiology|June 1, 2020
Driving Restrictions and Early Arrhythmias in Patients Receiving a Primary-Prevention Implantable Cardioverter-Defibrillator (DREAM-ICD) StudyChristian Steinberg, Christopher C Cheung, Darryl Wan, et al.
Circulation|April 12, 2012
Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardiaPierre Jaïs, Philippe Maury, Paul Khairy, et al.
Journal of the American College of Cardiology|June 4, 2013
Inverse relationship between fractionated electrograms and atrial fibrosis in persistent atrial fibrillation: combined magnetic resonance imaging and high-density mappingAmir S Jadidi, Hubert Cochet, Ashok J Shah, et al.
The Canadian Journal of Cardiology|August 5, 2019
Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and DesignLena Rivard, Paul Khairy, Mario Talajic, et al.
Journal of the American College of Cardiology|June 4, 2013
Validation of novel 3-dimensional electrocardiographic mapping of atrial tachycardias by invasive mapping and ablation: a multicenter studyAshok J Shah, Meleze Hocini, Olivier Xhaet, et al.
The New England Journal of Medicine|November 18, 2024
Catheter Ablation or Antiarrhythmic Drugs for Ventricular TachycardiaJohn L Sapp, Anthony S L Tang, Ratika Parkash, et al.
The Canadian Journal of Cardiology|November 6, 2020
Pulmonary Vein Stenosis After Atrial Fibrillation Ablation: Insights From the ADVICE TrialMichelle Samuel, Paul Khairy, François-Pierre Mongeon, et al.
CJC Open|September 18, 2023
Rationale and Design of the Randomized Bayesian Multicenter COME-TAVI Trial in Patients With a New Onset Left Bundle Branch BlockLena Rivard, Isabelle Nault, Andrew D Krahn, et al.
Nature Medicine|February 4, 2026
Publisher Correction: Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trialLéna Rivard, Paul Khairy, Mario Talajic, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|April 12, 2024
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillationStylianos Tzeis, Edward P Gerstenfeld, Jonathan Kalman, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
The Canadian Journal of Cardiology|June 1, 2020
Driving Restrictions and Early Arrhythmias in Patients Receiving a Primary-Prevention Implantable Cardioverter-Defibrillator (DREAM-ICD) StudyChristian Steinberg, Christopher C Cheung, Darryl Wan, et al.
Circulation|April 12, 2012
Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardiaPierre Jaïs, Philippe Maury, Paul Khairy, et al.
Journal of the American College of Cardiology|June 4, 2013
Inverse relationship between fractionated electrograms and atrial fibrosis in persistent atrial fibrillation: combined magnetic resonance imaging and high-density mappingAmir S Jadidi, Hubert Cochet, Ashok J Shah, et al.
The Canadian Journal of Cardiology|August 5, 2019
Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and DesignLena Rivard, Paul Khairy, Mario Talajic, et al.
Journal of the American College of Cardiology|June 4, 2013
Validation of novel 3-dimensional electrocardiographic mapping of atrial tachycardias by invasive mapping and ablation: a multicenter studyAshok J Shah, Meleze Hocini, Olivier Xhaet, et al.
The New England Journal of Medicine|November 18, 2024
Catheter Ablation or Antiarrhythmic Drugs for Ventricular TachycardiaJohn L Sapp, Anthony S L Tang, Ratika Parkash, et al.
The Canadian Journal of Cardiology|November 6, 2020
Pulmonary Vein Stenosis After Atrial Fibrillation Ablation: Insights From the ADVICE TrialMichelle Samuel, Paul Khairy, François-Pierre Mongeon, et al.
CJC Open|September 18, 2023
Rationale and Design of the Randomized Bayesian Multicenter COME-TAVI Trial in Patients With a New Onset Left Bundle Branch BlockLena Rivard, Isabelle Nault, Andrew D Krahn, et al.
Nature Medicine|February 4, 2026
Publisher Correction: Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trialLéna Rivard, Paul Khairy, Mario Talajic, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|April 12, 2024
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillationStylianos Tzeis, Edward P Gerstenfeld, Jonathan Kalman, et al.
Pageof 14